Twenty-Four-Hour Urinary Aldosterone Predicts Inappropriate Left Ventricular Mass Index in Patients with Primary Aldosteronism

Table 4

The correlation of urine aldosterone level and LV wall thickness, dimension, and LA size in patients with PA (groups 2 and 3).

	LVMI	Excess LVMI^†	LV mass	IVS	PW	LVEDD	LVESD	RWT	LA
Urine aldosterone	0.281*	0.265*	0.286*	0.300*	0.298*	0.149	0.037	0.150	0.170
PAC	0.020	0.057	0.019	0.064	0.094	−0.069	−0.061	−0.031	0.029
PRA	−0.046	−0.077	0.012	−0.043	−0.036	0.099	0.078	−0.179	−0.041
ARR	0.050	0.090	−0.005	0.061	0.064	−0.115	−0.093	0.157	0.048

IVS: interventricular septum; PW: posterior wall; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; RWT: relative wall thickness = 2 × PW/LVEDD; LA: left atrium.; PAC: plasma aldosterone concentration; PRA: plasma renin activity; ARR: plasma PAC-to-PRA ratio.
^∗𝑃<0.05.
†Excess LVMI = measured LVMI − predicted LVMI.